載入...
Histone deacetylase inhibition by Entinostat for the prevention of electrical and structural remodeling in heart failure
BACKGROUND: The development of heart failure is accompanied by complex changes in cardiac electrophysiology and functional properties of cardiomyocytes and fibroblasts. Histone deacetylase (HDAC) inhibitors hold great promise for the pharmaceutical therapy of several malignant diseases. Here, we des...
Na minha lista:
| 發表在: | BMC Pharmacol Toxicol |
|---|---|
| Main Authors: | , , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
BioMed Central
2019
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6404297/ https://ncbi.nlm.nih.gov/pubmed/30841920 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40360-019-0294-x |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|